NAD(P)H:quinone oxidoreductase 1 (NQO1), a phase II flavoenzyme that catalyzes reduction reactions to protect cells against electrophiles and oxidants, is involved in tumorigenesis. Altered methylation of the NQO1 gene has been observed and is speculated to result in aberrant NQO1 expression in rat cells undergoing chemical carcinogenesis, although this has not been proven experimentally. In this study, we first investigated the potential epigenetic mechanisms underlying the phenomenon of NQO1 differential expression in individual subclones of rat arsenic-transformed lung epithelial cells (TLECs). NQO1 expression of TLEC subclones with or without 5-aza-2′-deoxycytidine (5-Aza-CdR) treatment was assessed by reverse transcriptase-polymerase chain reaction (RT-PCR), western blot analysis, and realtime PCR. Methylation status of the NQO1 promoter in TLEC subclones was analyzed by bisulfite sequencing. Transcriptional activity of NQO1 promoter in vitro methylated was determined by luciferase assay using a CpG-free luciferase reporter driven by the NQO1 promoter region (−435 to +229). We found that non-CpG island (non-CpGI) within the NQO1 promoter was hyper-or hypo-methylated in TLEC subclones and corresponded to low and high gene expressions, respectively. Following the treatment with 5-Aza-CdR, transcription of the NQO1 gene in the hypermethylated subclones was restored, accompanied by demethylation of the NQO1 promoter. In vitro promoter methylation almost completely silenced reporter activity in TLECs. These results indicate that DNA methylation of the nonCpGI promoter contributes to epigenetic silencing of NQO1 in rat TLECs.
Introduction
NAD(P)H:quinone oxidoreductase 1 (NQO1) is a cytosolic flavoprotein that promotes the obligatory two-electron reduction of different quinones to their hydroquinone forms [1] . This enzyme is marked by its capacity to utilize NADH or NADPH as a reducing cofactor to prevent or decrease the formation of reactive oxygen species (ROS) [2, 3] . Generally, NQO1 is transcriptionally regulated by the nuclear factor erythroid 2-related factor 2 (Nrf2), which translocates to the nucleus and binds to the antioxidant response element (ARE) to activate NQO1 transcription when cells are under oxidative stress [4, 5] . Disruption of NQO1 can result in the alteration of intracellular redox status and overproduction of ROS, leading to toxicity, mutagenicity, and eventually tumorigenesis in various tissues [4, 6, 7] . NQO1 also inhibits p53 degradation through the ubiquitin proteasome pathway to increase p53 expression level in cells [8, 9] . Changes in NQO1 expression are considered to be important events in cell transformation and carcinogenesis [10, 11] .
Previous studies have indicated that arsenic induces lung cell transformation via the ROS pathway [12] . As an important member of the intracellular redox system, NQO1 was reported to be disrupted with the feature of differential expressions in lung cells exposed to arsenic [13] ; however, the mechanism underlying this phenomenon needs to be delineated. Williams et al. [14] reported that NQO1 became aberrantly methylated in the nodular tissue of rats during carcinogenesis and speculated that an increase in NQO1 transcription is probably due to demethylation, which was not taken into most researchers' consideration, since the promoter of rat NQO1 gene is a non-CpGI promoter according to the standard criteria [15] and the epigenetic effects of non-CpG island (non-CpGI) promoters have often been overlooked in the past. But recently, many genes with such promoters have been found to display an inverse correlation between methylation and expression in some tumor cells or normal tissue by genome-wide screening [16, 17] . Furthermore, accumulating evidence has confirmed that the epigenetic signatures of non-CpGI promoters may be almost identical to CpGI promoters [18] [19] [20] . Thus, in the present study, we attempted to determine experimentally whether non-CpGI promoter methylation is involved in the regulation of rat NQO1 expression during arsenic carcinogenesis. For this purpose, the arsenic-transformed lung epithelial cells (TLECs) were used in this study. TLECs were established by Li et al. [12] from the untransformed rat LECs by long-term arsenite treatment after a 24-h exposure to benzo(a)pyrene (B[α]P). We isolated six subclones from TLECs by cloning in soft agar and designated them as TSC1, TSC2, and so forth for our investigation.
By using reverse transcriptase-polymerase chain reaction (RT-PCR) and bisulfite sequencing, we initially analyzed the abnormal expression and promoter methylation of TLECs NQO1 gene and found that NQO1 was hypermethylated in subclones with low NQO1 expression compared with NQO1-overexpressing subclones. Then, treatment with the DNA methylation inhibitor 5-aza-2′-deoxycytidine (5-Aza-CdR), luciferase assays, and other cell-based experiments were performed to investigate the effects of methylation on gene transcription. Our results provide the first strong evidence that DNA methylation of a non-CpGI promoter inhibits NQO1 expression in rat TLECs.
Materials and Methods

Cell culture and drug treatment
Untransformed rat LECs and subclones of TLECs were cultured in F-12 medium (GIBCO, Carlsbad, USA) with 1.6 g/l sodium bicarbonate (Sigma, St Louis, USA), 10% fetal bovine serum (GIBCO), 100 U/ml penicillin, and 100 U/ml streptomycin (GIBCO). Cultures were maintained at 37°C in a humidified incubator with 5% CO 2 and 95% air. For NQO1 induction, cells were plated at a density of 5 × 10 5 cells/100 mm dish, treated with or without 0.5 μM 5-AzaCdR (Sigma) on the next day, and the medium was changed daily. DNA and RNA were extracted on the 8th day after treatment.
RT-PCR
Total RNA was isolated from cells with Trizol reagent (Invitrogen, Carlsbad, USA) and was reverse-transcribed using the Primescript ® RT Reagent Kit (Takara, Tokyo, Japan). Then, PCR was performed in a final reaction volume of 20 μl with 2 μl cDNA. Primer sequences were as follows: NQO1 forward, 5′-CAGAAACGACATCACAGGGGA-3′, reverse, 5′-CAGACGCTTCTTCCACCCTT-3′; Nrf2 forward, 5′-TGGCCAATTCAGAGTGGC-ATT-3′, reverse, 5′-AGAGTGGTGA CTCCTCCCAG-3′; and β-actin forward, 5′-CAGCCTTCCTTCCT GGGTATG-3′, reverse, 5′-AGGGTGTAAAACGCAGCTCA-3′. β-actin was used as the internal control. The PCR cycling protocol consisted of 3 min of initial denaturation at 94°C, followed by 25 cycles of 94°C for 30 sec, 55°C for 30 sec, and 72°C for 40 sec, and a final extension phase of 5 min at 72°C. The amplification reaction products were subjected to 1.5% agarose gel electrophoresis and visualized by ethidium bromide staining.
Real-time PCR
Real-time PCR (qPCR) was performed in triplicate using SYBR ® Premix ExTaq™II (Takara) reagents in a CFX96 Real-Time System (Bio-Rad, Hercules, USA) following the manufacturer's protocol. The primer sequences for NQO1 were as follows: 5′-TGGCCAATT CAGAGTGGCATT-3′ (forward) and 5′-AGAGTGGTGACTCCT CCCAG-3′ (reverse). And the primers for β-actin (the endogenous reference gene) were as follows: 5′-AGATCAAGATCATTGCTCCTCCT-3′ (forward) and 5′-ACGCAGCTCAGTAACAGTCC-3′ (reverse). The qPCR cycling conditions were as follows: 95°C for 3 min, followed by 40 cycles at 95°C for 15 sec and 60°C for 22 sec. Relative quantities of NQO1 transcript was calculated by the comparative C T method.
Western blot analysis
Cells were harvested, washed with phosphate-buffered saline, and lysed with ice-cold RIPA lysis buffer [50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% sodium dodecyl sulfate (SDS), 1% sodium deoxycholate, 1 mM PMSF, 5 μM leupeptin, 0.3 μM aprotinin, and 1 μM pepstatin] for 30 min. After protein quantitation with a BCA Protein Assay Kit (Pierce, Waltham, USA), 40 μg of each sample were separated by 10% SDS polyacrylamide gel electrophoresis and then electrophoretically transferred onto a nitrocellulose membrane. Transferred proteins were probed with anti-NQO1 (1:1000; Santa Cruz, Santa Cruz, USA), anti-Nrf2 (1:1000; Santa Cruz), and anti-β-actin (1:1000; Santa Cruz) antibodies, followed by probing with corresponding secondary antibodies (1:5000; Sigma) and were finally developed using the ECL Plus Chemiluminescence Reagent (Amersham Biosciences, Little Chalfont, UK).
Bisulfite-specific PCR and DNA sequencing
Genomic DNA was extracted from LECs and TLEC subclones with the TIANamp Genomic DNA Kit (Tiangen, Beijing, China). The extracted DNA (1 μg) was bisulfite-converted using the EpiTect Bisulfite Kit (Qiagen, Hilden, Germany) according to the manufacturer's guidelines. Then bisulfite-specific PCR (BSP) was performed to obtain −131 to +229 [defining the transcription start site (TSS) as +1] fragment of the non-CpGI promoter with the following primers: BSP-F, 5′-TGTTAATAATTTGGTATTTTTTTTTT-3′ and BSP-R, 5′-CCTAATCTCTACACTTTTCAACTTC-3′. BSP cycling condition were as follows: 94°C for 30 sec followed by 35 cycles of 94°C for 30 sec, 50°C for 30 sec, and 72°C for 35 sec, and a final extension of 72°C for 5 min. The BSP products were separated on 1.5% agarose gels and purified for cloning into the pGEM-T vector (Promega, Madison, USA). Ten randomly selected clones from each sample were sequenced with the ABI 3730xl DNA Analyzer (Applied Biosystems, Foster City, USA) to determine the CpG methylation status. The methylation level of NQO1 promoter was presented as the percentage of total methylated CpG sites within nucleotides −131 to +229 according to sequencing data obtained from 10 independent clones.
Construction of the pCpGL-NQO1 reporter
The regulatory elements of rat NQO1 have been identified [21, 22] . To obtain the NQO1 proximal promoter from −435 to +229 with the ARE sequence at the 5′ end, we used genomic DNA from LECs as a template and designed NQO1-F and NQO1-R primers for PCR. The primers contained BamHI and HindIII restriction sites at the 5′ and 3′ ends, respectively. The product was purified and then cloned into the CpG-less vector pCpGL-basic to generate the pCpGL-NQO1 plasmid, which was verified by sequencing. The primers used for cloning were as follows: NQO1-F, 5′-CGCGGATCCTCTAGAGTC ACAGTGACTTG-3′ and NQO1-R, 5′-AAAAAGCTTCCTAATCT CTACACTTTTCAACT-3′.
In vitro methylation of the pCpGL-NQO1 reporter
Plasmid pCpGL-NQO1 was in vitro methylated with the methytransferase enzymes M.SssI or M.HhaI (New England Biolabs, Ipswich, USA) in the presence of methyl group donor Sadenosylmethionine (SAM) for 5 h at 37°C. Three controls were incubated in the absence of either M.SssI or SAM or in the absence of the both. Then methylated and unmethylated plasmids were purified by ethanol precipitation. The efficacy of the in vitro methylation was confirmed by diagnostic digestion. Digestion was done on the methylated plasmids with MspI, a methylation-insensitive enzyme, and the methylation-sensitive isoschizomer HpaII.
Transfection and luciferase assays
LECs and two TLEC subclones, TSC5 and TSC6, were transiently transfected with 0.2 μg unmethylated or methylated reporter together with 0.1 μg pCMV-β-galactosidase (β-gal) using Lipofectamine reagent (Invitrogen). Luciferase activity was measured with the GloMax 20/20 Luminometer (Promega) using a Luciferase Reporter Assay Kit (Promega) and normalized to the corresponding β-gal activity.
Statistical analysis
Luciferase data, qPCR, and DNA methylation data are expressed as the mean ± standard deviation (SD) from three independent experiments and were analyzed with SPSS 13.0 statistical software (SPSS, Inc., Chicago, USA). The difference between groups in luciferase assays was analyzed with the two-tailed Student's t-test, and a P < 0.05 was considered statistically significant.
Results
NQO1 expression is aberrant in TLEC subclones
Having undergone random mutagenesis by B[α]P and long-term arsenic transformation, TLECs are a complex group of cells with different phenotypes resulting from changes in expression of multiple genes. As an important gene involved with cell transformation, the expressions of NQO1 in individual TLEC subclones were evaluated. It was found that NQO1 expression was low in TSC1, TSC3, TSC4, and TSC5 cells but was abundant in TSC2 and TSC6 cells compared with the untransformed LECs, at both the mRNA and protein levels (Fig. 1A,B) . These observations are consistent with other reports, which showed that NQO1 expression is significantly altered during the carcinogenesis of human cells [10, 23] .
Methylation status of the non-CpGI promoter of NQO1 in individual TLEC subclones
We initially confirmed that the rat NQO1 promoter did not contain a CpGI by analysis of the −500 to +500 residues using EMBOSS CpGplot online software (Fig. 2) . However, it is believed that nonCpGI promoter may play important roles in epigenetic regulation according to recent studies [18] [19] [20] . In addition, NQO1 transcription changes are reported to be probably due to aberrant gene methylation in rat nodular tissue, based on Southern blot analysis following restriction digestion with methylation-sensitive restriction enzymes [14] . To investigate whether abnormal expression of NQO1 in TLECs is directly related to DNA methylation, we determined the minimal fragment from −131 to +229 (360 bp) containing 14 CpG sites, GC box, TA box, and the Exon 1 (Figs. 2 and 3A) in the NQO1 non-CpGI promoter to analyze the methylation status by bisulfite sequencing. Our results revealed that the NQO1 promoter was heavily methylated in TSC1, TSC3, TSC4, and TSC5 cells but was completely unmethylated and slightly methylated in LEC, and TSC2 and TSC6 cells, respectively (Fig. 3B,C) . These data were consistent overall with the methylation status of the −475 to +482 interval (960 bp, 23 CpG sites; data not shown).
5-Aza-CdR induces NQO1 transcription in subclones with hypermethylated NQO1 promoter
Conventional RT-PCR showed that 5-Aza-CdR treatment significantly restored NQO1 mRNA expression in individual subclones with the hypermethylated promoter (especially in TSC1 and TSC5; Fig. 4A ). However, no apparent induction of NQO1 expression was observed in TSC2 and TSC6 cells, which had high expression of NQO1 (Fig. 4A) . A combination of qPCR and bisulfite sequencing revealed that the restoration of transcription corresponded with notable demethylation of the NQO1 promoter in the corresponding subclones (Fig. 4B,C) . In vitro DNA methylation silences NQO1 promoter activity
To investigate whether the NQO1 promoter is directly regulated via DNA methylation, we performed a luciferase reporter assay by utilizing the special luciferase vector-pCpGL-basic that is CpG-less [24] . Cells of all the TLEC subclones (TSC1-6) expressed high levels of Nrf2, the NQO1 activating gene (Fig. 5A,B) . Together with LEC cells, they were transfected with methylated and unmethylated pCpGL-NQO1 reporters which were driven by the NQO1 proximal promoter from −435 to +229 (Fig. 5C) . Data from the luciferase assay showed a similar trend in the three cell lines with very different expression of endogenous NQO1. TSC5 and TSC6 cells transfected with unmethylated plasmids (i.e. the three control plasmids) both showed generally high luciferase activities compared with the corresponding LECs. But the luciferase activities of TSC5 and TSC6 became very low or almost silenced when the promoter was methylated by the methytransferase enzyme M.SssI (Fig. 5D) . These results indicate that DNA methylation can directly inhibit non-CpGI promoter activity of NQO1. For further analysis, we used another methyltransferase M.HhaI that only methylates CpG in the specific 5′-GCGC-3′ sequence. It can merely catalyze two CpG sites' methylation within the promoter of NQO1 from −435 to +229. Significantly, M.HhaI decreased NQO1 promoter activity by 28.7% and 23.3% in TSC5 and TSC6 cells, respectively, suggesting that even minimal methylation can effectively suppress NQO1 transcription (Fig. 5D) . Moreover, we also observed the similar trends in human 293 T cells (Fig. 5F ). These results confirmed the efficacy of the in vitro methylation, as shown in Fig. 5E .
Discussion
Previous studies have shown that arsenic induces cell transformation through epigenetic regulation, i.e. alterations in histone acetylation and DNA methylation, consequently leading to the activation of pro-oncogenes and the suppression of anti-oncogenes [25] [26] [27] [28] . Arsenic-induced aberrant methylation not only occurs in promoters with conventional CpG islands such as p53 [29] but also occurs in genes with non-CpGI promoters. For example, after long-term oral administration of arsenic, methylation changes can be detected in a 500 bp non-CpGI region of the murine Ha-ras promoter but much less prominently in a 525 bp CpGI, which is believed to play a role in the regulation of NQO1 expression in arsenic-induced carcinogenesis [30] . In this study, NQO1, a crucial gene involved in cell tumorigenesis, was found to be differentially expressed in individual subclones of TLECs, with hypermethylation occurring in subclones with low NQO1 expression. Although the NQO1 promoter of TLECs is different from the human homolog which is thought to be regulated via CpGI hypermethylation [23] , 5-Aza-CdR treatment significantly restored NQO1 expression accompanied by a marked decline in promoter methylation of the hypermethylated subclones, suggesting that methylation of the non-CpGI promoter could result in important epigenetic effects on TLECs NQO1 expression.
To corroborate these findings, we constructed a pCpGL-NQO1 reporter, which encodes a luciferase gene driven by the NQO1 promoter (−435 to +229) containing an ARE at the 5′ end, and then performed luciferase assays. This reporter was generated using a novel CpG-free vector, pCpGL-basic, as traditional reporter vectors Bisulfite sequencing and qPCR confirmed that NQO1 restoration by 5-Aza-CdR treatment occurred concomitantly with significant demethylation in TLEC subclones exhibiting a hypermethylated non-CpGI promoter. Expression levels (white bars) of NQO1 were normalized to β-actin, and DNA methylation levels (black bars) were determined as described in the Methods section.
containing a large number of backbone CpG residues can strongly influence the activity of the reporter-driving promoter upon methylation in vitro, thereby compromising the experimental accuracy [24] . The results of our luciferase assay showed that transcriptional activity of the non-CpGI promoter could be directly suppressed by in vitro methylation in LECs, TSC5, and TSC6, as well as in human 293 T cells. Notably, in contrast to LECs, TSC5 cells, with low endogenous NQO1 transcription, displayed considerable luciferase activities much like TSC6 when transfected with unmethylated pCpGL-NQO1. This is presumably due to the upregulation of Nrf2 in TSC5 and TSC6 cells, since constitutively upregulated Nrf2 can facilitate transactivation of the NQO1 promoter and cause overexpression of this downstream gene [4, 31] . These results indicate that TSC5 also possesses the required factors to initiate NQO1 transcription and that methylation of the non-CpGI promoter is the key to gene silencing. In addition, M.HhaI, which methylates the reporter at only two CpG sites, exerts a notable suppression to the high transcriptional activity of the NQO1 promoter. These observations suggest that there are important cis-regulatory elements at these two and perhaps other positions within the −435 to +229 interval. It has been shown that a cytosine methylated within a cisregulatory sequence can even disrupt the binding of related transcription factors [32, 33] . It is also well known that methylbinding factors, such as MBD2 and MeCP2, can induce the recruitment of transcriptional repressors and architectural proteins for chromatin remodeling to suppress transcription [34] [35] [36] . Thus, it is possible that methylation of sparse CpGs is sufficient to silence NQO1 expression.
In conclusion, we demonstrated for the first time that DNA methylation of the NQO1 non-CpGI promoter could repress NQO1 gene expression in rat TLECs. Although more experimental work is required to illuminate the precise mechanism of transcription silencing, our study indicates that non-CpGI promoters also exert important functions in the epigenetic regulation of genes, such as NQO1, during arsenic-induced cell transformation, which should be taken into consideration in future studies. There are two specific sequences of 5′-CCGG-3′ within the NQO1 promoter cloned into the pCpGL vector. Methylation-insensitive enzyme MspI can digest the methylated CCGG sequence of pCpGL-NQO1 to produce a 360 bp fragment, while its isoschizomer HpaII fails. This result confirmed that pCpGL-NQO1 was completely in vitro methylated by M.SssI.
